Compounds > 1,3-dipropyl-8-(4-sulfophenyl)xanthine

1,3-dipropyl-8-(4-sulfophenyl)xanthine and quinoxalines

1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with quinoxalines in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albino-Teixeira, A; Guimarães, S; Moura, D; Paiva, MQ; Vaz-da-Silva, MJ	1

Other Studies

1 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and quinoxalines

Article	Year
Long-term administration of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX) alters alpha 2-adrenoceptor-mediated effects at the pre- but not at the postjunctional level. Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 350, Issue:6 Topics: Adrenergic alpha-Agonists; Animals; Arginine; Arteries; Brimonidine Tartrate; Hypertension; Male; Neuroeffector Junction; NG-Nitroarginine Methyl Ester; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Purinergic P1; Tail; Xanthines	1994

Article

Year

Long-term administration of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX) alters alpha 2-adrenoceptor-mediated effects at the pre- but not at the postjunctional level.

Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 350, Issue:6

Topics: Adrenergic alpha-Agonists; Animals; Arginine; Arteries; Brimonidine Tartrate; Hypertension; Male; Neuroeffector Junction; NG-Nitroarginine Methyl Ester; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Purinergic P1; Tail; Xanthines

1994